Clinical neuropharmacology

Keyphrases

Publications

2024

Senem Ertugrul Mut, Ferda Selcuk, Sıla Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology (2024)
Toji Miyagawa, Cynthia Vernon, Scott A Przybelski, Hoon-Ki Min, Julie A Fields, Kejal Kantarci, Val Lowe, Bradley F Boeve
Marked Decreased Tracer Binding in 123I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report. Clinical neuropharmacology (2024)
Danial Chowdhury, Caitlin McCarthy
Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report. Clinical neuropharmacology (2024)
Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, Igor D Bandeira, Daniela Faria-Guimarães, Samantha S Silva, Rodrigo P Mello, Gustavo C Leal, Aline S Sampaio, Lucas C Quarantini
Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review. Clinical neuropharmacology (2024)
Özdem Ertürk Çetin, Pınar Algedik, Gülcan Akyüz, Reyhan Sürmeli, Ümit Zanapalıoğlu, Gülce Alev Saltak, Şirin Güven
Minor/Major Congenital Malformations and Neurodevelopmental Outcomes in Children Prenatally Exposed to Levetiracetam, Lamotrigine, and Carbamazepine Monotherapy. Clinical neuropharmacology (2024)

volume 47, number 1, 2024

Toji Miyagawa, Cynthia Vernon, Scott A Przybelski, Hoon-Ki Min, Julie A Fields, Kejal Kantarci, Val Lowe, Bradley F Boeve
Marked Decreased Tracer Binding in 123 I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report. Clinical neuropharmacology 47 (1) (2024)
Toji Miyagawa, Cynthia Vernon, Scott A Przybelski, Hoon-Ki Min, Julie A Fields, Kejal Kantarci, Val Lowe, Bradley F Boeve
Marked Decreased Tracer Binding in 123 I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report. Clinical neuropharmacology 47 (1) (2024)
Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, Igor D Bandeira, Daniela Faria-Guimarães, Samantha S Silva, Rodrigo P Mello, Gustavo C Leal, Aline S Sampaio, Lucas C Quarantini
Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review. Clinical neuropharmacology 47 (1) (2024)
Toji Miyagawa, Cynthia Vernon, Scott A Przybelski, Hoon-Ki Min, Julie A Fields, Kejal Kantarci, Val Lowe, Bradley F Boeve
Marked Decreased Tracer Binding in 123 I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report. Clinical neuropharmacology 47 (1) (2024)
Toji Miyagawa, Cynthia Vernon, Scott A Przybelski, Hoon-Ki Min, Julie A Fields, Kejal Kantarci, Val Lowe, Bradley F Boeve
Marked Decreased Tracer Binding in 123 I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report. Clinical neuropharmacology 47 (1) (2024)
Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, Igor D Bandeira, Daniela Faria-Guimarães, Samantha S Silva, Rodrigo P Mello, Gustavo C Leal, Aline S Sampaio, Lucas C Quarantini
Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review. Clinical neuropharmacology 47 (1) (2024)

volume 47, number 2, 2024

Rui Zhang, Xuemei Zhao, Wenjing Li, Yu Gao
Refractory Anti- N -Methyl- d -Aspartate Receptor Autoimmune Encephalitis Induced by Ovarian Teratoma: A Case Report. Clinical neuropharmacology 47 (2) (2024)
Caleb Smack, Katherine Johnson, Noah Meester, Leah Shelton, Namrata Singh
A Patient With Minimally Conscious Syndrome Due to Cerebrovascular Accident Whose Symptoms Resolved With Zolpidem. Clinical neuropharmacology 47 (2) (2024)
Gabriela Tantillo, Nicole Davis, Justin Granstein, Ji Yeoun Yoo, Parul Agarwal, Kaitlin Reilly, Alexandra Reynolds, Gina Kayal, John Liang, Nathalie Jetté
Provider Experience With the Use of Ketamine for Refractory Status Epilepticus. Clinical neuropharmacology 47 (2) (2024)
Gabriela Tantillo, Nicole Davis, Justin Granstein, Ji Yeoun Yoo, Parul Agarwal, Kaitlin Reilly, Alexandra Reynolds, Gina Kayal, John Liang, Nathalie Jetté
Provider Experience With the Use of Ketamine for Refractory Status Epilepticus. Clinical neuropharmacology 47 (2) (2024)
Rui Zhang, Xuemei Zhao, Wenjing Li, Yu Gao
Refractory Anti- N -Methyl- d -Aspartate Receptor Autoimmune Encephalitis Induced by Ovarian Teratoma: A Case Report. Clinical neuropharmacology 47 (2) (2024)
Jon E Grant, Corine Driessens, Samuel R Chamberlain
Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial. Clinical neuropharmacology 47 (2) (2024)
Rui Zhang, Xuemei Zhao, Wenjing Li, Yu Gao
Refractory Anti- N -Methyl- d -Aspartate Receptor Autoimmune Encephalitis Induced by Ovarian Teratoma: A Case Report. Clinical neuropharmacology 47 (2) (2024)
Ting Wang, Yimo Feng
Exploration of Lasmiditan 200 mg Versus 100 mg for the Treatment of Migraine: A Meta-analysis Based on Aggregate Data. Clinical neuropharmacology 47 (2) (2024)
Ting Wang, Yimo Feng
Exploration of Lasmiditan 200 mg Versus 100 mg for the Treatment of Migraine: A Meta-analysis Based on Aggregate Data. Clinical neuropharmacology 47 (2) (2024)
Cemile Ozsurekci, Neslihan Kayahan Satis, Sultan Keskin Demircan, Mehmet İIlkin Naharcı
Association of Anticholinergic Drug Burden With Cognitive and Functional Decline Over Time in Dementia With Lewy Bodies: 1-Year Follow-Up Study. Clinical neuropharmacology 47 (2) (2024)
Takahiko Nagamine, Takeshi Watanabe, Akira Toyofuku
QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome. Clinical neuropharmacology 47 (2) (2024)
Takahiko Nagamine, Takeshi Watanabe, Akira Toyofuku
QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome. Clinical neuropharmacology 47 (2) (2024)
Ting Wang, Yimo Feng
Exploration of Lasmiditan 200 mg Versus 100 mg for the Treatment of Migraine: A Meta-analysis Based on Aggregate Data. Clinical neuropharmacology 47 (2) (2024)

volume 47, number 3, 2024

Pinar Aydogan Avşar, Merve Akkuş
ZO-1 Serum Levels as a Potential Biomarker for Psychotic Disorder. Clinical neuropharmacology 47 (3) (2024)
Pinar Aydogan Avşar, Merve Akkuş
ZO-1 Serum Levels as a Potential Biomarker for Psychotic Disorder. Clinical neuropharmacology 47 (3) (2024)
Megan Ralston, Alim Osman, Pavan Suryadevara, Elissa Cleland
Effect of Ketamine Treatment on Social Withdrawal in Autism and Autism-Like Conditions. Clinical neuropharmacology 47 (3) (2024)
Vinay Suresh, Mainak Bardhan, Tirth Dave, Muhammad Aaqib Shamim, Dilip Suresh, Poorvikha Satish, Bishal Dhakal, Aman Bhonsale, Priyanka Roy, Bijaya Kumar Padhi, Teshamae Monteith
Zavegepant for Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical neuropharmacology 47 (3) (2024)
Li Zhou, Xue Bai, Bowen Wu, Yongjun Tan, Mengxia Li, Qin Yang
Characterizing Vitamin B12 Deficiency in Neurology Outpatients: A Retrospective Observational Study. Clinical neuropharmacology 47 (3) (2024)
Li Zhou, Xue Bai, Bowen Wu, Yongjun Tan, Mengxia Li, Qin Yang
Characterizing Vitamin B12 Deficiency in Neurology Outpatients: A Retrospective Observational Study. Clinical neuropharmacology 47 (3) (2024)
David R Spiegel
The Emergency Department and Psychiatric Boarding: A Model for the Future. Clinical neuropharmacology 47 (3) (2024)
Saizheng Weng, Rongyan Zheng, Ruiqian Lin
Correlation of Serum High-Sensitivity C-Reactive Protein, Homocysteine, and Macrophage Migration Inhibitory Factor Levels With Symptom Severity and Cognitive Function in Patients With Schizophrenia. Clinical neuropharmacology 47 (3) (2024)
Vinay Suresh, Mainak Bardhan, Tirth Dave, Muhammad Aaqib Shamim, Dilip Suresh, Poorvikha Satish, Bishal Dhakal, Aman Bhonsale, Priyanka Roy, Bijaya Kumar Padhi, Teshamae Monteith
Zavegepant for Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical neuropharmacology 47 (3) (2024)
Saizheng Weng, Rongyan Zheng, Ruiqian Lin
Correlation of Serum High-Sensitivity C-Reactive Protein, Homocysteine, and Macrophage Migration Inhibitory Factor Levels With Symptom Severity and Cognitive Function in Patients With Schizophrenia. Clinical neuropharmacology 47 (3) (2024)
Beyazit Garip, Burcu Buzkan, Suleyman Demir
Retinal Tear Following Low-Frequency Repetitive Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder. Clinical neuropharmacology 47 (3) (2024)
Megan Ralston, Alim Osman, Pavan Suryadevara, Elissa Cleland
Effect of Ketamine Treatment on Social Withdrawal in Autism and Autism-Like Conditions. Clinical neuropharmacology 47 (3) (2024)
Raymond Klevor, Mariama Jarti, Mohamed Chraa, Nissrine Louhab, Khadija Krati, Najib Kissani
Metronidazole-Induced Encephalopathy With Probable Crohn Encephalitis: A Case Report. Clinical neuropharmacology 47 (3) (2024)

volume 47, number 4, 2024

Senem Ertugrul Mut, Ferda Selcuk, Sila Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology 47 (4) (2024)
Juan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, Liliana Patrucco, Magdalena Casas, Berenice Silva, Jimena Miguez, Norma Deri, Carlos Vrech, Susana Liwacki, Raúl Piedrabuena, Emanuel Silva, Verónica Tkachuk, Marcos Burgos, Dario Tavolini, Gisela Zanga, Amelia Alvez Pinheiro, Javier Hryb, Felisa Leguizamon, Eduardo Knorre, Pablo A Lopez, Alejandra Martinez, Adriana Carrá, Marina Alonso Serena, Edgardo Cristiano, Jorge Correale, Orlando Garcea, Nora Fernandez Liguori, Edgar Carnero Contentti
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina. Clinical neuropharmacology 47 (4) (2024)
Jiancheng Qiu, Yifei Gong, Xiucui Zhang, Weibing Mao
Effectiveness of Mindfulness-Based Cognitive Therapy on Depressive Symptoms, Brain Potential, and Neuroimmunoinflammatory Factors in Depressed Patients. Clinical neuropharmacology 47 (4) (2024)
Giovanni Gosch Berton, Amanda Cyntia Lima Fonseca Rodrigues, Rafael Dos Santos Borges, Nicole Rodrigues Cardoso, Thiago Abrahão de Oliveira, Marcos Vinícius Oliveira Marques
Abelson Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review, Meta-analysis, and Meta-regression. Clinical neuropharmacology 47 (4) (2024)
Danial Chowdhury, Caitlin McCarthy
Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report. Clinical neuropharmacology 47 (4) (2024)
Jiancheng Qiu, Yifei Gong, Xiucui Zhang, Weibing Mao
Effectiveness of Mindfulness-Based Cognitive Therapy on Depressive Symptoms, Brain Potential, and Neuroimmunoinflammatory Factors in Depressed Patients. Clinical neuropharmacology 47 (4) (2024)
Juan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, Liliana Patrucco, Magdalena Casas, Berenice Silva, Jimena Miguez, Norma Deri, Carlos Vrech, Susana Liwacki, Raúl Piedrabuena, Emanuel Silva, Verónica Tkachuk, Marcos Burgos, Dario Tavolini, Gisela Zanga, Amelia Alvez Pinheiro, Javier Hryb, Felisa Leguizamon, Eduardo Knorre, Pablo A Lopez, Alejandra Martinez, Adriana Carrá, Marina Alonso Serena, Edgardo Cristiano, Jorge Correale, Orlando Garcea, Nora Fernandez Liguori, Edgar Carnero Contentti
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina. Clinical neuropharmacology 47 (4) (2024)
Juan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, Liliana Patrucco, Magdalena Casas, Berenice Silva, Jimena Miguez, Norma Deri, Carlos Vrech, Susana Liwacki, Raúl Piedrabuena, Emanuel Silva, Verónica Tkachuk, Marcos Burgos, Dario Tavolini, Gisela Zanga, Amelia Alvez Pinheiro, Javier Hryb, Felisa Leguizamon, Eduardo Knorre, Pablo A Lopez, Alejandra Martinez, Adriana Carrá, Marina Alonso Serena, Edgardo Cristiano, Jorge Correale, Orlando Garcea, Nora Fernandez Liguori, Edgar Carnero Contentti
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina. Clinical neuropharmacology 47 (4) (2024)
Juan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, Liliana Patrucco, Magdalena Casas, Berenice Silva, Jimena Miguez, Norma Deri, Carlos Vrech, Susana Liwacki, Raúl Piedrabuena, Emanuel Silva, Verónica Tkachuk, Marcos Burgos, Dario Tavolini, Gisela Zanga, Amelia Alvez Pinheiro, Javier Hryb, Felisa Leguizamon, Eduardo Knorre, Pablo A Lopez, Alejandra Martinez, Adriana Carrá, Marina Alonso Serena, Edgardo Cristiano, Jorge Correale, Orlando Garcea, Nora Fernandez Liguori, Edgar Carnero Contentti
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina. Clinical neuropharmacology 47 (4) (2024)
Senem Ertugrul Mut, Ferda Selcuk, Sila Usar İncirli, Sedef Delibas
Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clinical neuropharmacology 47 (4) (2024)
Danial Chowdhury, Caitlin McCarthy
Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report. Clinical neuropharmacology 47 (4) (2024)
Giovanni Gosch Berton, Amanda Cyntia Lima Fonseca Rodrigues, Rafael Dos Santos Borges, Nicole Rodrigues Cardoso, Thiago Abrahão de Oliveira, Marcos Vinícius Oliveira Marques
Abelson Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review, Meta-analysis, and Meta-regression. Clinical neuropharmacology 47 (4) (2024)
Jiancheng Qiu, Yifei Gong, Xiucui Zhang, Weibing Mao
Effectiveness of Mindfulness-Based Cognitive Therapy on Depressive Symptoms, Brain Potential, and Neuroimmunoinflammatory Factors in Depressed Patients. Clinical neuropharmacology 47 (4) (2024)